Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helle Christiansen

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|February 22, 2007
[Use of rating scales with adult brain tumour patients]Helle Christiansen, Michael Kosteljanetz
Ugeskrift for Laeger|January 12, 2011
[Breast milk as a cause of group B streptococcal sepsis]Helle Christiansen, Helle Leth
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|February 11, 2005
Renal endpoints in hypertension trialsHelle Christiansen, Julian Segura, Luis M Ruilope
Therapeutic Innovation & Regulatory Science|February 7, 2022
Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial DatabasesHelle Christiansen, Steffen Thirstrup, Christine Erikstrup Hallgreen
Frontiers in Medicine|November 17, 2022
Mandatory requirements for pediatric drug development in the EU and the US for novel drugs-A comparative studyHelle Christiansen, Marie L De Bruin, Christine E Hallgreen
Current Hypertension Reports|September 2, 2003
How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?Julian Segura, Helle Christiansen, Carlos Campo, et al.
Plos One|April 4, 2022
Guidance for pediatric use in prescription information for novel medicinal products in the EU and the USHelle Christiansen, Marie L De Bruin, Sven Frokjaer, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 6, 2017
Corrigendum to "Protein-based nanotoxicology assessment strategy" [Nanomed Nanotechnol Biol Med. 2017;13(3):1229-1233]Marlene Pedersen Elnegaard, Markus List, Helle Christiansen, et al.
Paediatric Drugs|August 12, 2022
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal ProductsAnn-Katrine Birkelund Mogensen, Helle Christiansen, Marie Louise De Bruin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 9, 2017
Protein-based nanotoxicology assessment strategyMarlene Pedersen Elnegaard, Markus List, Helle Christiansen, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|February 22, 2007
[Use of rating scales with adult brain tumour patients]Helle Christiansen, Michael Kosteljanetz
Ugeskrift for Laeger|January 12, 2011
[Breast milk as a cause of group B streptococcal sepsis]Helle Christiansen, Helle Leth
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|February 11, 2005
Renal endpoints in hypertension trialsHelle Christiansen, Julian Segura, Luis M Ruilope
Therapeutic Innovation & Regulatory Science|February 7, 2022
Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial DatabasesHelle Christiansen, Steffen Thirstrup, Christine Erikstrup Hallgreen
Frontiers in Medicine|November 17, 2022
Mandatory requirements for pediatric drug development in the EU and the US for novel drugs-A comparative studyHelle Christiansen, Marie L De Bruin, Christine E Hallgreen
Current Hypertension Reports|September 2, 2003
How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?Julian Segura, Helle Christiansen, Carlos Campo, et al.
Plos One|April 4, 2022
Guidance for pediatric use in prescription information for novel medicinal products in the EU and the USHelle Christiansen, Marie L De Bruin, Sven Frokjaer, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 6, 2017
Corrigendum to "Protein-based nanotoxicology assessment strategy" [Nanomed Nanotechnol Biol Med. 2017;13(3):1229-1233]Marlene Pedersen Elnegaard, Markus List, Helle Christiansen, et al.
Paediatric Drugs|August 12, 2022
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal ProductsAnn-Katrine Birkelund Mogensen, Helle Christiansen, Marie Louise De Bruin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 9, 2017
Protein-based nanotoxicology assessment strategyMarlene Pedersen Elnegaard, Markus List, Helle Christiansen, et al.
Pageof 3